SYMPLICITY HTN-4 to potentially expand access for additional patients at risk for cardiovascular complications related to uncontrolled hypertension.
The Lotus Valve System (Boston Scientific) met a key performance measure in the treatment of symptomatic patients with severe aortic valve stenosis considered at high risk for surgical valve replacement, according to new data released today at the Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco, USA (27 October–1 November).
The use of novel oral anticoagulants (NOACs) has increased rapidly in Ontario, Canada, especially in people aged 85 years and over, in the 2 years since the drugs were approved for use in patients with atrial fibrillation (AF), according to new research published in CMAJ Open. This rapid increase signals the need to evaluate outcomes from the use of these drugs in an elderly, high-risk population much older than the population involved in the studies.
The European Commission recently adopted two measures to improve the safety of medical devices. The newly adopted measures were announced on September 24 as part of the joint plan for immediate action agreed upon between the Commission and the European Union member states. An analysis of the measures was published on October 22 in The Wall Street Journal.
The results of a survey amongst medical device companies in Europe about the financial impact of the upcoming changes in the European medical device regulation show a significant increase in costs for bringing new devices to patients. In addition to the necessary €7.5 billion investment to ensure the safety of patients, an additional €17.5 billion would be necessary to finance a centralised pre-marketing authorisation system as proposed by the European Parliament’s Rapporteur.
NHS England is inviting specialist hospitals to take part in a new, innovative commissioning approach called ‘commissioning through evaluation’, which is aimed at increasing access to services or treatments which are not currently routinely funded by the NHS. The NHS revision of Clinical Policy Commissioning Statement on SIRT will allow patients in England with metastatic colorectal cancer and intrahepatic cholangiocarcinoma who may benefit from SIR-Spheres microspheres to get treatment in specialist NHS centres, a press release from Sirtex states.
AngioDynamics featured its key innovative products and technologies, including the Angiovac cannula and circuit, Bioflo peripherally inserted central catheters, the Nanoknife system, Nevertouch direct fibre and the Acculis microwave system at CIRSE 2013
At the European Society for Vascular Surgery Annual Meeting (18–21 September 2013, Budapest, Hungary), Abeera Abbas, Academic Surgery Unit, Institute of Cardiovascular Sciences, University of Manchester, UK, presented the results from a pilot study which suggested that 3D contrast-enhanced ultrasound may be more sensitive to detect endoleaks when compared to both CT angiography and 2D contrast-enhanced ultrasound.
Interventional News spoke to Tim A Fischell, professor of Medicine, Michigan State University, USA, about the first use of a novel, endovascular approach using chemical neurolysis via periadventitial injection of dehydrated ethanol to perform renal artery denervation. Catheter-based renal denervation is a novel treatment option for patients with resistant arterial hypertension
Preliminary data presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) annual scientific meeting (14–18 September, Barcelona, Spain) demonstrated that TVA Medical’s vascular catheter-based FLEX System can create autogenous arteriovenous fistulas (AV fistulas) for haemodialysis patients with 94% procedural success.
It is now possible for members and non-members to submit abstracts online for the Society of Interventional Radiology’s (SIR’s) annual scientific meeting, to be held 22–27 March 2014 in San Diego, USA.
Twelve patients who were available for follow-up had good results at one year with the bioconvertible Sentry inferior vena cava filter (Novate), data presented at CIRSE 2013 shows.
Informing patients about the important details of interventional radiology procedures, before getting permission to conduct an intervention, is an important task that should be carried out by a specialist, a new study recommends.
An international prospective, randomised, multicentre trial that compared stenting using SE Astron Pulsar and Pulsar-18 (both from Biotronik) vs. angioplasty alone, failed to show statistically significant improved outcomes for stenting.
On 17 September, Boston Scientific announced the opening of the China branch of the Boston Scientific Institute for Advancing Science (IAS) as well as its new Innovation Center in Shanghai, China. The IAS will offer training in clinical practice and multidisciplinary programmes in Interventional Cardiology, Cardiac Rhythm Management and Electrophysiology, Endoscopy, Peripheral Interventions and Urology and Women’s Health.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos